评估以色列"痴呆症朋友"计划在增加知识和减少对痴呆症的耻辱感方面的有效性
Aviya Riabzev1, Perla Werner2, Shiri Shinan-Altman3
1Music Therapy Department, Faculty of Music Education, The Academic College Levinsky-Wingate, Tel Aviv-Yafo, Israel.
Journal of Alzheimer's disease : JAD
|January 22, 2026
概括
以色列痴呆症朋友计划改善了痴呆症知识和情绪反应. 然而,与痴呆症耻辱相关的歧视行为需要在教育计划之外进行进一步的干预.
科学领域:
- 公共卫生 公共卫生
- 老年学是一门学科.
- 社会心理学 社会心理学
背景情况:
- 痴呆症是一个重大的全球公共卫生挑战,由知识差距和耻辱加剧.
- 痴呆症朋友计划旨在提高社区对痴呆症的理解和态度.
- 它在非英国环境中的有效性,比如以色列,需要进一步评估.
研究的目的:
- 评估以色列痴呆症朋友计划对痴呆症知识和耻辱的影响.
- 调查感知易感性,痴呆熟悉性和自我感知变化机构与这些结果之间的关系.
主要方法:
- 一个前后研究设计,在基线有820名参与者,在3个月后续有205名参与者.
- 调查问卷测量了主观/客观痴呆知识,耻辱 (情绪反应,歧视行为),感知易感性和变化代理.
- 使用t测试,ANOVA和回归分析分析的数据.
主要成果:
- 观察到主观和客观痴呆知识的显著增加 (p<0.05).
- 积极的情绪反应有所改善 (p=0.012),负面的情绪反应有所减少 (p=0.05).
- 与痴呆症耻辱相关的歧视行为没有显著变化 (p=0.75).
结论:
- 参与痴呆症朋友计划提高了痴呆症知识和积极的情绪反应.
- 持续的歧视行为表明,需要全面的战略,以充分解决痴呆症的耻辱感.
- 高等教育与知识获取相关;感知敏感性降低与负面情绪反应和歧视的减少有关.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Community Based Intervention
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


